Literature DB >> 12579103

Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.

Alessandro Parolari1, Susanna Colli, Luciana Mussoni, Sonia Eligini, Moreno Naliato, Xin Wang, Sara Gandini, Elena Tremoli, Paolo Biglioli, Francesco Alamanni.   

Abstract

OBJECTIVES: The alterations of the coagulation-fibrinolytic profile immediately and up to few days after cardiac surgery have been widely documented. However, less information is available on whether these alterations persist for prolonged periods of time after the operation. In this study we have evaluated the coagulation-fibrinolytic profile of patients who underwent coronary artery surgery with cardiopulmonary bypass during a 2-month follow-up period.
METHODS: Twenty-six patients (age range, 50-75 years) were studied. Blood samples were collected before the intervention and at different time points postoperatively up to 2 months after the operation. Measurement of selected coagulation-fibrinolytic variables was carried out in plasma from 16 patients. Evaluation of tissue factor activity determined as procoagulant activity was performed in peripheral blood mononuclear leukocytes obtained from 10 patients.
RESULTS: Antigenic levels of clottable fibrinogen, prothrombin fragment F1.2, D-dimer, and thrombin-antithrombin complex were significantly increased during the first week after the intervention compared with preoperative values. Prothrombin fragment F1.2 levels returned to normal within 15 days, fibrinogen levels normalized within 30 days, and thrombin-antithrombin complex levels normalized at 45 days, whereas D-dimer values were still significantly higher 60 days postoperatively respective to baseline values. There was a trend toward an increased procoagulant activity from peripheral blood mononuclear leukocytes 4 days after the operation, whereas no changes of factor VII measured either as antigen or in its coagulant and activated forms were recorded throughout the study.
CONCLUSIONS: A marked activation of the coagulation-fibrinolytic system occurs after cardiopulmonary bypass and lasts for at least 2 months thereafter. This finding suggests that these alterations might account for the increased thrombotic risk of these patients during the postoperative period.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12579103     DOI: 10.1067/mtc.2003.2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Autotransfusion management during and after cardiopulmonary bypass alters fibrin degradation and transfusion requirements.

Authors:  Alice Wiefferink; Patrick W Weerwind; Waander van Heerde; Steven Teerenstra; Luc Noyez; Ben E de Pauw; René M H J Brouwer
Journal:  J Extra Corpor Technol       Date:  2007-06

Review 2.  Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-01-23       Impact factor: 2.300

3.  Accuracy of continuous central venous oxygen saturation monitoring in patients undergoing cardiac surgery.

Authors:  Werner Baulig; Alexander Dullenkopf; Andreas Kobler; Barbara Baulig; Hans Rudolf Roth; Edith R Schmid
Journal:  J Clin Monit Comput       Date:  2008-04-29       Impact factor: 2.502

4.  Excess risk of venous thromboembolism in hip fracture patients and the prognostic impact of comorbidity.

Authors:  A B Pedersen; V Ehrenstein; S K Szépligeti; H T Sørensen
Journal:  Osteoporos Int       Date:  2017-09-05       Impact factor: 4.507

5.  Activation of coagulation and fibrinolysis during coronary artery bypass grafting: a comparison between on-pump and off-pump techniques.

Authors:  Shreosee Roy; Kaushik Saha; Krishnendu Mukherjee; Santanu Dutta; Debasis Mukhopadhyay; Indranil Das; Gargi Raychaudhuri
Journal:  Indian J Hematol Blood Transfus       Date:  2013-04-26       Impact factor: 0.900

Review 6.  Coagulation disorders of cardiopulmonary bypass: a review.

Authors:  Domenico Paparella; Stephanie J Brister; Michael R Buchanan
Journal:  Intensive Care Med       Date:  2004-07-24       Impact factor: 17.440

7.  Paroxysmal Atrial Fibrillation: An Independent Risk Factor for Prothrombotic Conditions.

Authors:  Mariya Negreva; Krasimira Prodanova; Ana Zarkova
Journal:  J Atr Fibrillation       Date:  2020-08-31

8.  Postoperative Heparin-Mediated Extracorporeal Low-Density Lipoprotein Fibrinogen Precipitation Aphaeresis Prevents Early Graft Occlusion after Coronary Artery Bypass Grafting.

Authors:  Martin Oberhoffer; Sandra Eifert; Beate Jaeger; Frithjof Blessing; A Beiras-Fernandez; D Seidel; B Reichart
Journal:  Surg J (N Y)       Date:  2016-05-10

9.  Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study.

Authors:  Hua Yan; Xieraili Tiemuerniyazi; Yangwu Song; Fei Xu; Wei Feng
Journal:  J Cardiothorac Surg       Date:  2020-06-29       Impact factor: 1.637

Review 10.  Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?

Authors:  Alessandro Parolari; Paolo Poggio; Veronika Myasoedova; Paola Songia; Giorgia Bonalumi; Alberto Pilozzi; Davide Pacini; Francesco Alamanni; Elena Tremoli
Journal:  Front Cardiovasc Med       Date:  2016-01-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.